Concepedia

Targeted Therapy Response

Targeted Therapy Response is a therapeutic outcome measure that specifically assesses the biological or clinical effect of a precision intervention directed at molecular abnormalities driven by oncogene amplification or overexpression.

23

Publications

1.6K

Citations

281

Authors

73

Institutions

Publications per year

2017–2026

13

Parents

Publications

23

Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative

Apostolia M. Tsimberidou, Nancy G. Iskander, David S. Hong et al. · Clinical Cancer Research · 2012 · 541 citations · Full text

, , +17

Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection

Wungki Park, Jiapeng Chen, Joanne F. Chou et al. · Clinical Cancer Research · 2020 · 226 citations · Full text

, , +16

Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR-Mutated Advanced NSCLC

Youjin Kim, Boram Lee, Joonho Shim et al. · Journal of Thoracic Oncology · 2018 · 191 citations · Full text

, , +14

Potential Unreliability of Uncommon ALK, ROS1, and RET Genomic Breakpoints in Predicting the Efficacy of Targeted Therapy in NSCLC

Weihua Li, Lei Guo, Yutao Liu et al. · Journal of Thoracic Oncology · 2020 · 120 citations · Full text

, , +17

A Comprehensive PDX Gastric Cancer Collection Captures Cancer Cell–Intrinsic Transcriptional MSI Traits

Simona Corso, Claudio Isella, Sara E. Bellomo et al. · Cancer Research · 2019 · 113 citations · Full text

, , +17

1–5 of 23

Authors

281

  1. RK
    Razelle Kurzrock

    The University of Texas MD Anderson Cancer Center, United States

    2 publications · 569 citations

    2

    h-index

  2. MF
    Michael F. Berger

    Memorial Sloan Kettering Cancer Center, United States

    2 publications · 247 citations

    2

    h-index

  3. JJ
    Jennifer J. Wheler

    The University of Texas MD Anderson Cancer Center, United States

    2 publications · 569 citations

    2

    h-index

  4. AM
    Apostolia M. Tsimberidou

    The University of Texas MD Anderson Cancer Center, United States

    2 publications · 569 citations

    2

    h-index

  5. SA
    Sarina A. Piha‐Paul

    The University of Texas MD Anderson Cancer Center, United States

    2 publications · 569 citations

    2

    h-index

1–5 of 281

Institutions

73

  1. The University of Texas MD Anderson Cancer Center

    Houston, United States

    3 h-index

    28 publications

    8K citations

  2. Memorial Sloan Kettering Cancer Center

    New York, United States

    3 h-index

    48 publications

    7.4K citations

  3. Washington University in St. Louis

    St Louis, United States

    3 h-index

    16 publications

    330 citations

  4. Cornell University

    Ithaca, United States

    2 h-index

    25 publications

    5.4K citations

  5. Dana-Farber Cancer Institute

    Boston, United States

    2 h-index

    7 publications

    725 citations

  6. Heidelberg University

    Heidelberg, Germany

    2 h-index

    27 publications

    450 citations

  7. University Hospital Heidelberg

    Heidelberg, Germany

    2 h-index

    24 publications

    402 citations

  8. Mayo Clinic in Arizona

    Scottsdale, United States

    2 h-index

    3 publications

    115 citations

1–8 of 73

Venues

  1. Journal of Clinical Oncology

    3 publications · 62 citations

    3

    h-index

  2. Clinical Cancer Research

    3 publications · 788 citations

    3

    h-index

  3. Journal of Thoracic Oncology

    2 publications · 311 citations

    2

    h-index

  4. Molecular Imaging and Biology

    MIB · 1 publications · 57 citations

    1

    h-index

  5. Family & Community Health

    FCH · 1 publications · 22 citations

    1

    h-index

1–5